{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:46:19Z","timestamp":1793245579643,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Prior studies investigating associations of rheumatoid factor (RF) and anti\u2013citrullinated protein antibody (ACPA) seropositivity with risk for rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) have mostly used cross-sectional or case\u2013control designs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether combined autoantibody seropositivity and higher individual autoantibody concentrations were associated with increased risk for RA-ILD in a prospective RA cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Within the Veterans Affairs Rheumatoid Arthritis prospective registry, we performed a cross-sectional study of prevalent ILD and a retrospective cohort study of incident ILD (diagnosed after at least 12 mo of longitudinal follow-up). We used logistic and Cox regression methods to determine whether combined RF\/ACPA seropositivity and higher autoantibody concentrations were independently associated with greater risk for prevalent and incident ILD, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 2,328 participants (median age 64 yr, 89.3% male), 100 (4.3%) subjects had prevalent ILD at enrollment. During 14,281 patient-years of follow-up, 83 (3.7%) of the remaining 2,228 were subsequently diagnosed with incident ILD (5.8 cases per 1,000 person-years). Patients with combined RF\/ACPA seropositivity had a higher probability of prevalent ILD compared with seronegative subjects (odds ratio [OR], 2.90; 95% confidence interval [CI], 1.24\u20136.78). RF titers demonstrated a monotonic association with prevalent ILD (OR, 2.69; 95% CI, 1.11\u20136.51 for low-positive [15\u201345 IU\/ml] titers; OR, 3.40; 95% CI, 1.61\u20137.18 for high-positive [&amp;gt;45 IU\/ml] titers; P for trend 0.01). Patients with high-positive (&amp;gt;15 U\/ml) ACPA titers were also at higher risk for prevalent ILD (OR, 1.91; 95% CI, 1.04\u20133.49) compared with ACPA-negative subjects. Combined RF\/ACPA seropositivity was not associated with increased risk for incident ILD, nor were high- or low-positive RF or ACPA titers. In a piecewise linear spline model, however, RF titers greater than 90 IU\/ml independently correlated with increased risk for incident ILD (hazard ratio, 1.68, 95% CI, 1.02\u20132.77).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combined RF\/ACPA seropositivity and individual autoantibody concentrations were strongly associated with prevalent but not incident RA-ILD. Only patients with RF concentrations &amp;gt;90 IU\/ml were observed to be at higher risk of incident RA-ILD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202006-590oc","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T16:13:43Z","timestamp":1602087223000},"page":"598-605","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":60,"title":["Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of U.S. Veterans"],"prefix":"10.1093","volume":"18","author":[{"given":"Jake G.","family":"Natalini","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care, Department of Medicine"},{"name":"Center for Clinical Epidemiology and Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua F.","family":"Baker","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, and"},{"name":"Division of Rheumatology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania"},{"name":"Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina D.","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punyasha","family":"Roul","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey M.","family":"Thiele","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska"},{"name":"VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Sauer","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, University of Utah School of Medicine, Salt Lake City, Utah; and"},{"name":"VA Salt Lake City Health Care System, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheilonda R.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care, Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Kawut","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care, Department of Medicine"},{"name":"Center for Clinical Epidemiology and Biostatistics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted R.","family":"Mikuls","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska"},{"name":"VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant R.","family":"England","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska"},{"name":"VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"2026012203472757400_bib1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012203472757400_bib2","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2026012203472757400_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0272-5231(05)70109-X","article-title":"Pulmonary manifestations of rheumatoid arthritis","volume":"19","author":"Tanoue","year":"1998","journal-title":"Clin Chest Med"},{"key":"2026012203472757400_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203472757400_bib5","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/rheumatology\/kez177","article-title":"The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment","volume":"58","author":"Duarte","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2026012203472757400_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3899\/jrheum.171315","article-title":"Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality","volume":"46","author":"Raimundo","year":"2019","journal-title":"J Rheumatol"},{"key":"2026012203472757400_bib7","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/rheumatology\/keq135","article-title":"Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years","volume":"49","author":"Bartels","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2026012203472757400_bib8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026012203472757400_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ccm.2019.05.003","article-title":"Thoracic manifestations of rheumatoid arthritis","volume":"40","author":"Esposito","year":"2019","journal-title":"Clin Chest Med"},{"key":"2026012203472757400_bib10","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026012203472757400_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203472757400_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"key":"2026012203472757400_bib13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026012203472757400_bib14","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics: a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2026012203472757400_bib15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/ard.2009.122739","article-title":"Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis","volume":"69","author":"Miriovsky","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026012203472757400_bib16","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/thoraxjnl-2016-208932","article-title":"Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis","volume":"71","author":"Bernstein","year":"2016","journal-title":"Thorax"},{"key":"2026012203472757400_bib17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","article-title":"Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Restrepo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2026012203472757400_bib18","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1172\/JCI28756","article-title":"Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis","volume":"116","author":"Rangel-Moreno","year":"2006","journal-title":"J Clin Invest"},{"key":"2026012203472757400_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.38201","article-title":"Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis","volume":"66","author":"Reynisdottir","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026012203472757400_bib20","first-page":"24","article-title":"Insights and implications of the VA rheumatoid arthritis registry","volume":"32","author":"Mikuls","year":"2015","journal-title":"Fed Pract"},{"key":"2026012203472757400_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2026012203472757400_bib22","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5","article-title":"Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format","volume":"42","author":"Pincus","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2026012203472757400_bib23","first-page":"579","article-title":"Development of a disease activity score based on judgment in clinical practice by rheumatologists","volume":"20","author":"van der Heijde","year":"1993","journal-title":"J Rheumatol"},{"key":"2026012203472757400_bib24","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.40900","article-title":"Malondialdehyde-acetaldehyde adducts and antibody responses in rheumatoid arthritis-associated interstitial lung disease","volume":"71","author":"England","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026012203472757400_bib25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/acr.24043","article-title":"Performance of administrative algorithms to identify interstitial lung disease in rheumatoid arthritis","volume":"72","author":"England","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026012203472757400_bib26","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026012203472757400_bib27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12350-014-9908-2","article-title":"Survival analysis and regression models","volume":"21","author":"George","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"2026012203472757400_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jcrc.2016.07.017","article-title":"Immortal time bias in observational studies of time-to-event outcomes","volume":"36","author":"Jones","year":"2016","journal-title":"J Crit Care"},{"key":"2026012203472757400_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev.pu.12.050191.001433","article-title":"Competing risks in mortality analysis","volume":"12","author":"Chiang","year":"1991","journal-title":"Annu Rev Public Health"},{"key":"2026012203472757400_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmjebm-2018-110972","article-title":"\u2018Depletion of the susceptibles\u2019 taught through a story, a table and basic arithmetic","volume":"23","author":"Stovitz","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"2026012203472757400_bib31","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026012203472757400_bib32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203472757400_bib33","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026012203472757400_bib34","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"2026012203472757400_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/art.41123","article-title":"Comparative profiling of serum protein biomarkers in rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis","volume":"72","author":"Kass","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2026012203472757400_bib36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2026012203472757400_bib37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/1529-0131(199805)41:5<817::AID-ART7>3.0.CO;2-S","article-title":"The influence of sex on the phenotype of rheumatoid arthritis","volume":"41","author":"Weyand","year":"1998","journal-title":"Arthritis Rheum"},{"key":"2026012203472757400_bib38","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1002\/art.22120","article-title":"Influence of male sex on disease phenotype in familial rheumatoid arthritis","volume":"54","author":"Jawaheer","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/18\/4\/598\/66338828\/annalsats_18_4_598.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/18\/4\/598\/66338828\/annalsats_18_4_598.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:53:12Z","timestamp":1769071992000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/18\/4\/598\/8419546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202006-590oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4]]},"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"2020-06-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}